© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 8, 617-629,
April 17, 2002
© 2002 Oxford University Press
ARTICLE |
Reproductive Hormone-Induced, STAT3-Mediated Interleukin 6 Action in Normal and Malignant Human Ovarian Surface Epithelial Cells
Affiliations of authors: V. Syed (Department of Surgery), S.-M. Ho (Department of Surgery and Cell Biology), University of Massachusetts Medical School, Worcester; G. Ulinski, Worcester Polytechnic Institute, Worcester; S. C. Mok, Laboratory of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston.
Correspondence to: Shuk-Mei Ho, Ph.D., Department of Surgery, University of Massachusetts Medical School, 55 Lake Ave. North, Worcester, MA 01655 (e-mail: shuk-mei.ho{at}umassmed.edu).
Background: Reproductive hormones are associated with risk for epithelial ovarian cancer. To determine the effect of such hormones on the activation of interleukin 6 (IL-6)/STAT3 (signal transducer and activator of transcription-3) signaling, which may be involved in ovarian cancer, we investigated the status of STAT3, IL-6, and its receptor in immortalized human ovarian surface epithelial (HOSE) and ovarian cancer (OVCA) cell lines. Methods: Two immortalized HOSE cell lines and two OVCA cell lines were cultured with gonadotropins, sex steroid hormones, and/or IL-6, alone or with specific inhibitors or IL-6-neutralizing antibodies. Expression of IL-6, the IL-6 receptor
chain (IL-6R
), and phosphorylated and unphosphorylated STAT3 messenger RNAs (mRNAs) and proteins in all cells was determined. Cell proliferation and soft-agar colony formation were assessed. STAT3 activity was investigated in OVCA cells transfected with a dominant negative STAT3 (Dn-STAT3), wild-type STAT3, or an empty control vector. All statistical tests were two-sided. Results: Levels of IL-6 mRNA and protein increased in all cells treated with follicle-stimulating hormone (FSH), luteinizing hormone (LH), 17
-estradiol, or estrone but increased only in OVCA cells treated with testosterone and 5
-dihydrotestosterone. For all lines, IL-6 antibodies partially inhibited hormone-stimulated cell proliferation but completely inhibited IL-6-enhanced cell proliferation. IL-6 induced STAT3 phosphorylation and activation in HOSE cells; STAT3 was constitutively activated in OVCA cells. Higher levels of IL-6R
and STAT3 transcription factors were observed in OVCA cells than in HOSE cells. After transfection, Dn-STAT3 suppressed endogenous STAT3 and inhibited all forms of IL-6-stimulated OVCA cell proliferation (OVCA 429 cells, P<.001; OVCA 432 cells, P<.006), whereas wild-type STAT3 enhanced HOSE cell proliferation (wild-type STAT3 at 0.5 µg/mL in HOSE 306 cells, P<.002; STAT3 at 1.0 µg/mL in HOSE 306 or both concentrations of wild-type STAT3 in HOSE 642 cells, P<.001). Conclusions: The IL-6/STAT3 signaling pathway may mediate FSH-, LH-, and estrogen-stimulated HOSE cell proliferation. Increased IL-6R
expression and constitutive STAT3 activation may be associated with ovarian cancer.
This article has been cited by other articles:
![]() |
J.-H. Choi, C.-L. Chen, S. L. Poon, H.-S. Wang, and P. C K Leung Gonadotropin-stimulated epidermal growth factor receptor expression in human ovarian surface epithelial cells: involvement of cyclic AMP-dependent exchange protein activated by cAMP pathway Endocr. Relat. Cancer, March 1, 2009; 16(1): 179 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kato, A. Sadarangani, S. Lange, A. M. Delpiano, M. Vargas, J. Branes, J. Carvajal, S. Lipkowitz, G. I. Owen, and M. A. Cuello 2-Methoxyestradiol Mediates Apoptosis Through Caspase-Dependent and Independent Mechanisms in Ovarian Cancer Cells But Not in Normal Counterparts Reproductive Sciences, November 1, 2008; 15(9): 878 - 894. [Abstract] [PDF] |
||||
![]() |
Z. Duan, J. Bradner, E. Greenberg, R. Mazitschek, R. Foster, J. Mahoney, and M. V. Seiden 8-Benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic Acid (SD-1008), a Novel Janus Kinase 2 Inhibitor, Increases Chemotherapy Sensitivity in Human Ovarian Cancer Cells Mol. Pharmacol., November 1, 2007; 72(5): 1137 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Choi, A. S. T. Wong, H.-F. Huang, and P. C. K. Leung Gonadotropins and Ovarian Cancer Endocr. Rev., June 1, 2007; 28(4): 440 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C.K. Leung and J.-H. Choi Endocrine signaling in ovarian surface epithelium and cancer Hum. Reprod. Update, March 1, 2007; 13(2): 143 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kulbe, R. Thompson, J. L. Wilson, S. Robinson, T. Hagemann, R. Fatah, D. Gould, A. Ayhan, and F. Balkwill The Inflammatory Cytokine Tumor Necrosis Factor-{alpha} Generates an Autocrine Tumor-Promoting Network in Epithelial Ovarian Cancer Cells Cancer Res., January 15, 2007; 67(2): 585 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. F. Liu, R. K. H. Lo, C. S. S. Wong, C. Morris, H. Wise, and Y. H. Wong Activation of STAT3 by G{alpha}s Distinctively Requires Protein Kinase A, JNK, and Phosphatidylinositol 3-Kinase J. Biol. Chem., November 24, 2006; 281(47): 35812 - 35825. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Duan, J. E. Bradner, E. Greenberg, R. Levine, R. Foster, J. Mahoney, and M. V. Seiden SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear Translocation. Clin. Cancer Res., November 15, 2006; 12(22): 6844 - 6852. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Choi, K.-C. Choi, N. Auersperg, and P. C.K. Leung Gonadotropins Activate Proteolysis and Increase Invasion through Protein Kinase A and Phosphatidylinositol 3-Kinase Pathways in Human Epithelial Ovarian Cancer Cells. Cancer Res., April 1, 2006; 66(7): 3912 - 3920. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Nilsson, R. R. Langley, and I. J. Fidler Interleukin-6, Secreted by Human Ovarian Carcinoma Cells, Is a Potent Proangiogenic Cytokine Cancer Res., December 1, 2005; 65(23): 10794 - 10800. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Drakes, T. G. Blanchard, and S. J. Czinn Colon lamina propria dendritic cells induce a proinflammatory cytokine response in lamina propria T cells in the SCID mouse model of colitis J. Leukoc. Biol., December 1, 2005; 78(6): 1291 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nishimoto, Y. Yu, Z. Lu, X. Mao, Z. Ren, S. S. Watowich, G. B. Mills, W. S-L. Liao, X. Chen, R. C. Bast Jr., et al. A Ras Homologue Member I Directly Inhibits Signal Transducers and Activators of Transcription 3 Translocation and Activity in Human Breast and Ovarian Cancer Cells Cancer Res., August 1, 2005; 65(15): 6701 - 6710. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Choi, K.-C. Choi, N. Auersperg, and P. C K Leung Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells Endocr. Relat. Cancer, June 1, 2005; 12(2): 407 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Allavena, M. Signorelli, M. Chieppa, E. Erba, G. Bianchi, F. Marchesi, C. O. Olimpio, C. Bonardi, A. Garbi, A. Lissoni, et al. Anti-inflammatory Properties of the Novel Antitumor Agent Yondelis (Trabectedin): Inhibition of Macrophage Differentiation and Cytokine Production Cancer Res., April 1, 2005; 65(7): 2964 - 2971. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Chou, L.-H. Wei, M.-L. Kuo, Y.-J. Huang, K.-P. Lai, C.-A. Chen, and C.-Y. Hsieh Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-{kappa}B pathway by lysophosphatidic acid, an ovarian cancer-activating factor Carcinogenesis, January 1, 2005; 26(1): 45 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Choi, K.-C. Choi, N. Auersperg, and P. C. K. Leung Overexpression of Follicle-Stimulating Hormone Receptor Activates Oncogenic Pathways in Preneoplastic Ovarian Surface Epithelial Cells J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5508 - 5516. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Herbeuval, E. Lelievre, C. Lambert, M. Dy, and C. Genin Recruitment of STAT3 for Production of IL-10 by Colon Carcinoma Cells Induced by Macrophage-Derived IL-6 J. Immunol., April 1, 2004; 172(7): 4630 - 4636. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Steiner, S. Godoy-Tundidor, H. Rogatsch, A. P. Berger, D. Fuchs, B. Comuzzi, G. Bartsch, A. Hobisch, and Z. Culig Accelerated in Vivo Growth of Prostate Tumors that Up-Regulate Interleukin-6 Is Associated with Reduced Retinoblastoma Protein Expression and Activation of the Mitogen-Activated Protein Kinase Pathway Am. J. Pathol., February 1, 2003; 162(2): 655 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Auersperg and H. Ziltener Re: Reproductive Hormone-Induced, STAT3-Mediated Interleukin 6 Action in Normal and Malignant Human Ovarian Surface Epithelial Cells J Natl Cancer Inst, August 21, 2002; 94(16): 1255 - 1256. [Full Text] [PDF] |
||||













